SKN | Israel-Based Ocular Disease Biotech Tarsier Pharma Sets Terms for $45 Million U.S. IPO
Tarsier Pharma, an Israel-based biotechnology company focused on ocular inflammatory diseases, has set terms for a $45 million U.S. IPO as it advances the...
SKN | Can SolarEdge Technologies Sustain Its Sharp Rebound as Global Solar Markets Recover?
SolarEdge Technologies, Inc. has returned to investor focus following a sharp rally in its share price as markets reassess growth prospects across the renewable...
SKN | Future Money Acquisition Corporation Ordinary Shares: SPAC Vehicle Targets Selective Capital Market Reopening
Future Money Acquisition Corporation is moving toward an initial public offering of its ordinary shares, targeting approximately $8 million US in gross proceeds as...
SKN | Elevation Series Trust: Multi-Strategy Investment Platform Eyes IPO Amid Shifting ETF and Fund Market Dynamics
Elevation Series Trust is preparing for an initial public offering targeting approximately $8 million US in gross proceeds as it seeks to expand its...
SKN | Talos Energy Expands Offshore and Carbon Capture Strategy Amid Energy Market Volatility
Talos Energy Gains Investor Attention as Oil Markets Stabilize
Talos Energy Inc. continues attracting market attention as energy investors evaluate offshore production growth, commodity price...